Clinical Trial Update: Hyperpolarized 13C Pyruvate MRI for Early Immune Evaluation in Cervical Cancer Patients At Baseline and CCRT Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting the completion of a study evaluating hyperpolarized 13C pyruvate MRI as an early immune evaluation tool in cervical cancer patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED